Angiotech Announces Additional Diameters of Sutures to Further Expand Its Quill SRS PDO Product Line

Angiotech Pharmaceuticals, Inc., a global specialty pharmaceutical and medical device company, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to begin marketing additional diameters of its Quill Self-Retaining System (SRS) Polydioxanone (PDO) product line.
CNN